VolitionRx Limited (VNRX)
After hours:
| Previous close | 0.7276 |
| Open | 0.7158 |
| Bid | 0.6800 x 900 |
| Ask | 0.7400 x 1400 |
| Day's range | 0.6600 - 0.7200 |
| 52-week range | 0.5500 - 1.7900 |
| Volume | |
| Avg. volume | 200,544 |
| Market cap | 56.321M |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4500 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.73 |
- GuruFocus.com
VolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...
Discover how VolitionRX Ltd is enhancing its financial structure and advancing key technologies for future growth.
PR NewswireVolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the first quarter of 2024. Volition management will host a conference call tomorrow, May 14 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.
PR NewswireVolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, May 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter 2024, in addition to providing a business update. Details of this event can also be found below.
